Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'TO-MODERATE HYPERTENSION' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 98 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. McNally, P
      Considerations for drug therapy in hypertension

      INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    2. McGill, JB
      Angiotensin II receptor antagonist plus a thiazide diuretic is more efficacious for treating hypertension than either drug alone

      BLOOD PRESSURE MONITORING
    3. Littlejohn, TW
      Clinical considerations in hypertensive black patients: the role of angiotensin II receptor blockers in combination with a diuretic

      BLOOD PRESSURE MONITORING
    4. Lacourciere, Y
      Usefulness of combination therapy in hypertensive patients who do not respond to an angiotensin type 1 receptor antagonist alone

      BLOOD PRESSURE MONITORING
    5. Lacourciere, Y; Tytus, R; O'Keefe, D; Lenis, J; Orchard, R; Martin, K
      Efficacy and tolerability of a fixed-dose combination of telmisartan plus hydrochlorothiazide in patients uncontrolled with telmisartan monotherapy

      JOURNAL OF HUMAN HYPERTENSION
    6. Novo, S; Abrignani, MG; Novo, G; Nardi, E; Dominguez, LJ; Strano, A; Barbagallo, M
      Effects of drug therapy on cardiac arrhythmias and ischemia in hypertensives with LVH

      AMERICAN JOURNAL OF HYPERTENSION
    7. Mann, SJ; Gerber, LM
      Low-dose alpha/beta blockade in the treatment of essential hypertension

      AMERICAN JOURNAL OF HYPERTENSION
    8. Meredith, P; Trenkwalder, P
      Angiotensin II antagonists for hypertension: There are differences in efficacy

      AMERICAN JOURNAL OF HYPERTENSION
    9. Matalka, K; El-Thaher, T; Saleem, M; Arafat, T; Jehanli, A; Badwan, A
      Enzyme linked immunosorbent assay for determination of amlodipine in plasma

      JOURNAL OF CLINICAL LABORATORY ANALYSIS
    10. Meredith, PA
      Clinical comparative trials of angiotensin II type 1 (AT(1))-receptor blockers

      BLOOD PRESSURE
    11. Waeber, B
      Achieving blood pressure targets in the management of hypertension

      BLOOD PRESSURE
    12. Mancia, G
      Clinical differences among angiotensin II receptor antagonists

      BLOOD PRESSURE
    13. Mounier-Vehier, C; Devos, P
      Angiotensin II receptor antagonists: are they all the same?

      PRESSE MEDICALE
    14. Marino, MR; Vachharajani, NN
      Drug interactions with irbesartan

      CLINICAL PHARMACOKINETICS
    15. van der Does, R; Euler, R
      A randomized, double-blind, parallel-group study to compare the anti-hypertensive effects of imidapril and nifedipine in the treatment of mild-to-moderate essential hypertension

      JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
    16. Schierok, H; Pairet, M; Hauel, N; Wienen, W
      Effects of telmisartan on renal excretory function in conscious dogs

      JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
    17. Lenz, TL; Wurdeman, RL; Hilleman, DE
      Comparison of 24-hour blood pressure profiles in patients with hypertension who were switched from amlodipine to nisoldipine

      PHARMACOTHERAPY
    18. Ross, SD; Akhras, KS; Zhang, SH; Rozinsky, M; Nalysnyk, L
      Discontinuation of antihypertensive drugs due to adverse events: A systematic review and meta-analysis

      PHARMACOTHERAPY
    19. Yilmaz, F; Isbir, T; Agachan, B; Aydin, M
      Is epsilon 4 allele of apolipoprotein E associated with more severe end-organ damage in essential hypertension?

      CELL BIOCHEMISTRY AND FUNCTION
    20. Stangier, J; Su, CAPF; van Heiningen, PNM; Meinicke, T; van Lier, JJ; de Bruin, H; Tamminga, WJ; Jonkman, JHG
      Inhibitory effect of telmisartan on the blood pressure response to angiotensin II challenge

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    21. Claxton, AJ; Cramer, J; Pierce, C
      A systematic review of the associations between dose regimens and medication compliance

      CLINICAL THERAPEUTICS
    22. Richter, A; Ostrowski, C; Dombeck, MP; Gondek, K; Hutchinson, JL
      Delphi panel study of current hypertension treatment patterns

      CLINICAL THERAPEUTICS
    23. Kostis, JB; Klapholz, M; Delaney, C; Vesterqvist, O; Cohen, M; Manning, JA; Jemal, M; Kollia, GD; Liao, WC
      Pharmacodynamics and pharmacokinetics of omapatrilat in heart failure

      JOURNAL OF CLINICAL PHARMACOLOGY
    24. Lama, A; Oliva, L
      New concepts in hypertension

      REVISTA MEDICA DE CHILE
    25. Kirch, W; Horn, B; Schweizer, J
      Comparison of angiotensin II receptor antagonists

      EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
    26. Sharpe, M; Jarvis, B; Goa, KL
      Telmisartan - A review of its use in hypertension

      DRUGS
    27. Waeber, B
      A review of irbesartan in anti hypertensive therapy: Comparison with otheranti hypertensive agents

      CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL
    28. Modesti, PA; Rocchi, F; Tedeschini, RC; Vetere, A; Burberi, F; Cecioni, I
      Blood pressure response to combination therapy with ramipril or captopril plus hydrochlorothiazide: A randomized, active-controlled, crossover study

      CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL
    29. Burnier, M
      Angiotensin II type 1 receptor blockers

      CIRCULATION
    30. Oparil, S
      Efficacy of perindopril in the treatment of systemic hypertension

      AMERICAN JOURNAL OF CARDIOLOGY
    31. Sica, DA
      Dosage considerations with perindopril for systemic hypertension

      AMERICAN JOURNAL OF CARDIOLOGY
    32. Cote, I; Gregoire, JP; Moisan, J
      Health-related quality-of-life measurement in hypertension - A review of randomised controlled drug trials

      PHARMACOECONOMICS
    33. Oatis, GM; Stowers, AD
      Conversion from amlodipine to felodipine ER: Did the change fulfill expectations?

      FORMULARY
    34. Dina, R; Jafari, M
      Angiotensin II-receptor antagonists: An overview

      AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    35. Tsioufis, C; Stefanadis, C; Antoniadis, D; Kallikazaros, I; Zambaras, P; Pitsavos, C; Tsiamis, E; Toutouzas, P
      Absence of any significant effects of circadian blood pressure variations on carotid artery elastic properties in essential hypertensive subjects

      JOURNAL OF HUMAN HYPERTENSION
    36. Mallion, JM; Baguet, JP
      Putting the efficacy of candesartan cilexetil into perspective: a review of new comparative data

      JOURNAL OF HUMAN HYPERTENSION
    37. Israili, ZH
      Clinical pharmacokinetics of angiotensin II (AT(1)) receptor blockers in hypertension

      JOURNAL OF HUMAN HYPERTENSION
    38. Haneda, T; Ogawa, Y; Kato, J; Matsuhashi, H; Morimoto, H; Honda, H; Takenaka, T; Tanazawa, S; Kataoka, R; Kikuchi, K
      Effect of celiprolol on cardiac hypertrophy in hypertension

      Hypertension research
    39. Conlin, PR; Spence, JD; Williams, B; Ribeiro, AB; Saito, I; Benedict, C; Bunt, AMG
      Angiotensin II antagonists for hypertension: Are there differences in efficacy?

      AMERICAN JOURNAL OF HYPERTENSION
    40. Gavras, H
      Update on the clinical pharmacology of candesartan cilexetil

      AMERICAN JOURNAL OF HYPERTENSION
    41. Lacourciere, Y; Poirier, L; Lefebvre, J
      A comparative review of the efficacy of antihypertensive agents on 24 h ambulatory blood pressure

      CANADIAN JOURNAL OF CARDIOLOGY
    42. Gottdiener, JS; Arnold, AM; Aurigemma, GP; Polak, JF; Tracy, RP; Kitzman, DW; Gardin, JM; Rutledge, JE; Boineau, RC
      Predictors of congestive heart failure in the elderly: The cardiovascular health study

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    43. Evans, M
      Justified deception? The single blind placebo in drug research

      JOURNAL OF MEDICAL ETHICS
    44. Shore, AC
      Capillaroscopy and the measurement of capillary pressure

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    45. Gonzalez-Juanatey, JR
      Do angiotensin II receptor antagonists substitute angiotensin converting enzyme inhibitors in the treatment of high blood pressure?

      REVISTA ESPANOLA DE CARDIOLOGIA
    46. Song, JC; White, CM
      Pharmacologic, pharmacokinetic, and therapeutic differences among angiotensin II receptor antagonists

      PHARMACOTHERAPY
    47. Asmar, P; Lacourciere, Y
      A new approach to assessing antihypertensive therapy: effect of treatment on pulse pressure

      JOURNAL OF HYPERTENSION
    48. Burnier, M; Brunner, HR
      Angiotensin II receptor antagonists

      LANCET
    49. Taal, MW; Brenner, BM
      Renoprotective benefits of RAS inhibition: From ACEI to angiotensin II antagonists

      KIDNEY INTERNATIONAL
    50. Leidy, NK; Schmier, JK; Bonomi, AE; Legro, M; Zyczynski, T; Kong, BW
      Psychometric properties of the VSQLQ in black patients with mild hypertension

      JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION
    51. Schwartzkopff, B; Mundhenke, M; Strauer, BE
      Arterial hypertension and heart failure

      INTERNIST
    52. Markham, A; Spencer, CM; Jarvis, B
      Irbesartan - An updated review of its use in cardiovascular disorders

      DRUGS
    53. Flack, JM; Yunis, C; Preisser, J; Holmes, CB; Mensah, G; McLean, B; Saunders, E
      The rapidity of drug dose escalation influences blood pressure response and adverse effects burden in patients with hypertension - The Quinapril Titration Interval Management Evaluation (ATIME) study

      ARCHIVES OF INTERNAL MEDICINE
    54. Zannad, F
      Nisoldipine coat-core and heart rate response during treatment of hypertension

      INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    55. Klocke, RK
      Tolerability of nisoldipine coat-core in hypertension

      CLINICAL DRUG INVESTIGATION
    56. Doyle, L; Flynn, A; Cashman, K
      The effect of magnesium supplementation on biochemical markers of bone metabolism or blood pressure in healthy young adult females

      EUROPEAN JOURNAL OF CLINICAL NUTRITION
    57. Zusman, RM
      Are there differences among angiotensin receptor blockers?

      AMERICAN JOURNAL OF HYPERTENSION
    58. Feldman, RD; Campbell, N; Larochelle, P; Bolli, P; Burgess, ED; Carruthers, G; Floras, JS; Haynes, RB; Honos, G; Leenen, FHH; Leiter, LA; Logan, AG; Myers, MG; Spence, JD; Zarnke, KB
      1999 Canadian recommendations for the management of hypertension

      CANADIAN MEDICAL ASSOCIATION JOURNAL
    59. Burgess, E; Lewanczuk, R; Bolli, P; Chockalingam, A; Cutler, H; Taylor, G; Hamet, P
      Recommendations on potassium, magnesium and calcium

      CANADIAN MEDICAL ASSOCIATION JOURNAL
    60. Wurdeman, RL; Mooss, AN; Mohiuddin, SM; Lucas, BD; Ryschon, KL; Hilleman, DE
      Comparison of 24-hour ambulatory blood pressure data in hypertensive patients switched from nifedipine-GITS to nifedipine-CC

      PHARMACOTHERAPY
    61. Willenheimer, R; Dahlof, B; Rydberg, E; Erhardt, L
      AT(1)-receptor blockers in hypertension and heart failure: clinical experience and future directions

      EUROPEAN HEART JOURNAL
    62. Hayduk, K; Kraul, H
      Efficacy and safety of spirapril in mild-to-moderate hypertension

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    63. Ruschitzka, FT; Noll, G; Luscher, TF
      Calcium antagonists - Results of recent studies and their significance forpractice

      INTERNIST
    64. Fotherby, MD; Panayiotou, B
      Antihypertensive therapy in the prevention of stroke - What, when and for whom?

      DRUGS
    65. Huraib, S; Tanimu, D; Abu Romeh, S; Iqbal, A
      Efficacy of fosinopril in the control of 24-hour blood pressure in hemodialysis patients using ambulatory blood pressure monitoring

      CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL
    66. Martina, B; Dieterle, T; Weinbacher, M; Battegay, E
      Effects of losartan titrated to losartan/hydrochlorothiazide and amlodipine on left ventricular mass in patients with mild-to-moderate hypertension -A double-blind randomized controlled study

      CARDIOLOGY
    67. Unger, T
      Significance of angiotensin type 1 receptor blockade: Why are angiotensin II receptor blockers different?

      AMERICAN JOURNAL OF CARDIOLOGY
    68. MARTINA B; WEINBACHER M; DREWE J; GASSER P
      EFFECTS OF LOSARTAN TITRATED TO LOSARTAN HYDROCHLOROTHIAZIDE AND AMLODIPINE ON BLOOD-PRESSURE AND PERIPHERAL CAPILLARY MICROCIRCULATION IN PATIENTS WITH MILD-TO-MODERATE HYPERTENSION/

      Journal of human hypertension
    69. Kawasaki, T; Itoh, K; Kawasaki, M
      Reduction in blood pressure with a sodium-reduced, potassium- and magnesium-enriched mineral salt in subjects with mild essential hypertension

      Hypertension research
    70. KASSLERTAUB K; LITTLEJOHN T; ELLIOTT W; RUDDY T; ADLER E
      COMPARATIVE EFFICACY OF 2 ANGIOTENSIN-II RECEPTOR ANTAGONISTS, IRBESARTAN AND LOSARTAN, IN MILD-TO-MODERATE HYPERTENSION

      American journal of hypertension
    71. RUDE RK
      MAGNESIUM-DEFICIENCY - A CAUSE OF HETEROGENOUS DISEASE IN HUMANS

      Journal of bone and mineral research
    72. Ambrosioni, E; Safar, M; Degaute, JP; Malin, PL; MacMahon, M; Pujol, DR; de Cordoue, A; Guez, D
      Low-dose antihypertensive therapy with 1.5 mg sustained-release indapamide: results of randomised double-blind controlled studies

      JOURNAL OF HYPERTENSION
    73. Leenen, FHH
      Regression of cardiac hypertrophy by 1,4 dihydropyridines in hypertensive patients

      JOURNAL OF HYPERTENSION
    74. HALL WD; REED JW; FLACH JM; YUNIS C; PREISSER J
      COMPARISON OF THE EFFICACY OF DIHYDROPYRIDINE CALCIUM-CHANNEL BLOCKERS IN AFRICAN-AMERICAN PATIENTS WITH HYPERTENSION

      Archives of internal medicine
    75. BERNADETMONROZIES P; POILLEUX E; SUC JM
      EVALUATION OF THE EFFICACY AND SAFETY OF DILTIAZEM 300 MG RETARD IN HYPERTENSIVE PATIENTS WITH CHRONIC-RENAL-FAILURE

      Annales de cardiologie et d'angeiologie
    76. MILNE RJ; VANDERHOORN S; JACKSON RT
      A PREDICTIVE MODEL OF THE HEALTH BENEFITS AND COST-EFFECTIVENESS OF CELIPROLOL AND ATENOLOL IN PRIMARY PREVENTION OF CARDIOVASCULAR-DISEASEIN HYPERTENSIVE PATIENTS

      PharmacoEconomics
    77. LANGTRY HD; MARKHAM A
      LISINOPRIL - A REVIEW OF ITS PHARMACOLOGY AND CLINICAL EFFICACY IN ELDERLY PATIENTS

      Drugs & aging
    78. GANDHI AJ; MURPHY CM; ZERVOPOULOS PC; EVANS RE; CARTER BL; BAUMAN JL
      EVALUATION OF 2 FORMS OF SUSTAINED-RELEASE NIFEDIPINE USING 24 H AMBULATORY BLOOD-PRESSURE MONITORING

      American journal of hypertension
    79. LACOURCIERE Y; POIRIER L; LEFEBVRE J; ARCHAMBAULT F; AVE SD; WARD C; LINDBERG E
      THE ANTIHYPERTENSIVE EFFICACY OF THE NOVEL CALCIUM-ANTAGONIST MIBEFRADIL IN COMPARISON WITH NIFEDIPINE GITS IN MODERATE TO SEVERE HYPERTENSIVES WITH AMBULATORY HYPERTENSION

      American journal of hypertension
    80. STASON WB; SCHMID CH; NIEDZWIECKI D; WHITING GW; LUO DH; ROSS SD; CHALMERS TC
      SAFETY OF NIFEDIPINE IN PATIENTS WITH HYPERTENSION - A METAANALYSIS

      Hypertension
    81. PATEL VB; SIDDIQ T; SHERWOOD R; RICHARDSON PJ; VICTOR R
      EFFECTS OF THE DIHYDROPYRIDINE CALCIUM-CHANNEL BLOCKER AMLODIPINE ON VENTRICULAR AND ATRIAL PROTEIN-SYNTHESIS IN AN AORTIC CONSTRICTION MODEL OF HYPERTENSION AND, FOLLOWING CHRONIC TREATMENT, IN THE LEFT-VENTRICLE OF SHR RATS

      International journal of cardiology
    82. VANREE JW; VANDERPOL GA
      LOW DOSAGES OF FELODIPINE ER ONCE-DAILY AS MONOTHERAPY IN ELDERLY HYPERTENSIVE PATIENTS - EFFECT ON AMBULATORY BLOOD-PRESSURE AND QUALITY-OF-LIFE

      Journal of human hypertension
    83. BYYNY RL; MERRILL DD; BRADSTREET TE; SWEET CS
      AN INPATIENT TRIAL OF THE SAFETY AND EFFICACY OF LOSARTAN COMPARED WITH PLACEBO AND ENALAPRIL IN PATIENTS WITH ESSENTIAL-HYPERTENSION

      Cardiovascular drugs and therapy
    84. ZANNAD F; MATZINGER A; LARCHE J
      TROUGH PEAK RATIOS OF ONCE-DAILY ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS AND CALCIUM-ANTAGONISTS/

      American journal of hypertension
    85. LEENEN FHH
      CLINICAL RELEVANCE OF 24 H BLOOD-PRESSURE CONTROL BY 1,4-DIHYDROPYRIDINES

      American journal of hypertension
    86. POISSON P; BAUER B; SCHUELER E; RANGOONWALA B
      RAMIPRIL AND FELODIPINE - A COMPARISON OF THE EFFICACY AND SAFETY OF MONOTHERAPY VERSUS COMBINATION THERAPY

      Current medical research and opinion
    87. VONCOSSEL G; WAGNER J; WIESE J; PURFURST WD; MINUTH M
      ATENOLOL AND NIFEDIPINE VERSUS NITRENDIPI NE - COMPARISON OF THE EFFICACY AND TOLERANCE AMONG PATIENTS WITH MILD-TO-MODERATE HYPERTENSION BY 24-HOUR BLOOD-PRESSURE MONITORING

      Nieren- und Hochdruckkrankheiten
    88. POSEREINO A; GONZALEZJUANATEY JR; PASTOR C; MENDEZ I; ESTEVEZ JC; CABEZASCERRATO J
      MYOCARDIC STRUCTURE AND A STUDY OF ARRHYT HMIAS DURING AMBULATORY ELECTROCARDIOGRAPHIC REGISTRY IN SLIGHT ESSENTIAL-HYPERTENSION

      Medicina Clinica
    89. RANGOONWALA B; SCHULZ W; BAUER B
      FIXED-DOSE COMBINATIONS OF ACE-INHIBITORS

      British journal of clinical practice
    90. JESPERSEN BA; JESPERSEN LT; PEDERSEN OL
      GREATER BLOOD-PRESSURE REDUCTION WITH FELODIPINE ER THAN WITH NITRENDIPINE IN HYPERTENSIVE PATIENTS - A 24-HOUR ABPM STUDY

      Clinical drug investigation
    91. DAHLOF B; KELLER SE; MAKRIS L; GOLDBERG AI; SWEET CS; LIM NY
      EFFICACY AND TOLERABILITY OF LOSARTAN POTASSIUM AND ATENOLOL IN PATIENTS WITH MILD-TO-MODERATE ESSENTIAL-HYPERTENSION

      American journal of hypertension
    92. SCHOENBERGER JA
      LOSARTAN WITH HYDROCHLOROTHIAZIDE IN THE TREATMENT OF HYPERTENSION

      Journal of hypertension
    93. CHRYSANT SG; COHEN M
      SUSTAINED BLOOD-PRESSURE CONTROL WITH CONTROLLED-RELEASE ISRADIPINE (ISRADIPINE-CR)

      Journal of clinical pharmacology
    94. DAVIS PJ; FAGAN TC; TOPMILLER MJ; LEVINE JH; FERDINAND KC
      TREATMENT OF MILD HYPERTENSION WITH LOW ONCE-DAILY DOSES OF A SUSTAINED-RELEASE CAPSULE FORMULATION OF VERAPAMIL

      Journal of clinical pharmacology
    95. TIRLAPUR V; BACKHOUSE CI; MILLER AJ
      A COMPARISON OF THE EFFICACY AND TOLERABILITY OF ONCE-DAILY CONTROLLED-RELEASE DILTIAZEM WITH TWICE-DAILY NIFEDIPINE-RETARD IN PATIENTS WITH ESSENTIAL-HYPERTENSION

      Journal of drug development
    96. KRAFT K; VETTER H
      24-HOUR BLOOD-PRESSURE PROFILES IN PATIENTS WITH MILD-TO-MODERATE HYPERTENSION - MOXONIDINE VERSUS CAPTOPRIL

      Journal of cardiovascular pharmacology
    97. HOFLING B; GRIMM CM; GROSS R; JOCHUMS H; KADEREIT U; KEMPER R; KIERDORF HD; LANDERSDORFER M; POETSCH W; SCHMID R; SELL R
      COMPARISON OF THE EFFICACY AND SAFETY OF DILTIAZEM AND CAPTOPRIL IN MILD-TO-MODERATE ESSENTIAL-HYPERTENSION

      Herz, Kreislauf
    98. LEWIN AJ; LUEG MC; TARGUM S; CARDENAS P
      A CLINICAL-TRIAL EVALUATING THE 24-HOUR EFFECTS OF BISOPROLOL HYDROCHLOROTHIAZIDE 5 MG 6.25 MG COMBINATION IN PATIENTS WITH MILD-TO-MODERATE HYPERTENSION/

      Clinical cardiology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 16/02/20 alle ore 20:34:48